INCB50465-801 Rollover (7008420

Clinical Trial Grant

Duke Scholars

Principal Investigator Matthew Stuart McKinney Medicine, Hematologic Malignancies and Cellular Therapy

Administered By

Duke Cancer Institute

Awarded By

Incyte Corporation

Start Date

September 22, 2023

End Date

September 30, 2028

Administered By

Duke Cancer Institute

Awarded By

Incyte Corporation

Start Date

September 22, 2023

End Date

September 30, 2028